Education
About Us
Working with TipRanks
Follow Us
Kindstar Globalgene Technology, Inc. (HK:9960)
:9960
RESEARCH TOOLSreports
9960 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.93 - HK$1.54
Previous CloseN/A
Volume114.00K
Average Volume (3M)1.10M
Market Cap
HK$1.59B
Enterprise ValueHK$1.37B
Total Cash (Recent Filing)HK$1.66B
Total Debt (Recent Filing)¥398.36M
Price to Earnings (P/E)130.8
Beta0.55
Next Earnings
Sep 02, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 09, 2025Dividend Yield1.17%
Share Statistics
EPS (TTM)-0.08
Shares Outstanding1,040,758,400
10 Day Avg. Volume1,326,650
30 Day Avg. Volume1,095,716
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)0.45
Price to Sales (P/S)0.00
P/FCF Ratio-8.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Kindstar Globalgene Technology, Inc. News
PremiumCompany Announcements
Kindstar Globalgene Announces Board Changes
PremiumCompany Announcements
Kindstar Globalgene Establishes Nomination Committee for Enhanced Governance
PremiumCompany Announcements
Kindstar Globalgene Successfully Passes All AGM Resolutions
PremiumCompany Announcements
Kindstar Globalgene Announces Virtual AGM and Key Resolutions
PremiumCompany Announcements
Kindstar Globalgene Reports Revenue Decline and Net Loss for 2024
PremiumCompany Announcements
Kindstar Globalgene Announces Final Dividend for 2024
PremiumCompany Announcements
Kindstar Globalgene Issues Profit Warning Amid Economic ChallengesOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.82%
Mutual Funds
― Other Institutional Investors
99.18% Public Companies and
Individual Investors
9960 FAQ
What was Kindstar Globalgene Technology, Inc.’s price range in the past 12 months?
Kindstar Globalgene Technology, Inc. lowest stock price was HK$0.93 and its highest was HK$1.54 in the past 12 months.
What is Kindstar Globalgene Technology, Inc.’s market cap?
Kindstar Globalgene Technology, Inc.’s market cap is HK$1.59B.
When is Kindstar Globalgene Technology, Inc.’s upcoming earnings report date?
Kindstar Globalgene Technology, Inc.’s upcoming earnings report date is Sep 02, 2025 which is in 35 days.
How were Kindstar Globalgene Technology, Inc.’s earnings last quarter?
Kindstar Globalgene Technology, Inc. released its earnings results on Mar 28, 2025. The company reported -HK$0.078 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.078.
Is Kindstar Globalgene Technology, Inc. overvalued?
According to Wall Street analysts Kindstar Globalgene Technology, Inc.’s price is currently Overvalued.
Does Kindstar Globalgene Technology, Inc. pay dividends?
Kindstar Globalgene Technology, Inc. pays a Annually dividend of HK$0.024 which represents an annual dividend yield of 1.17%. See more information on Kindstar Globalgene Technology, Inc. dividends here
What is Kindstar Globalgene Technology, Inc.’s EPS estimate?
Kindstar Globalgene Technology, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kindstar Globalgene Technology, Inc. have?
Kindstar Globalgene Technology, Inc. has 1,040,758,400 shares outstanding.
What happened to Kindstar Globalgene Technology, Inc.’s price movement after its last earnings report?
Kindstar Globalgene Technology, Inc. reported an EPS of -HK$0.078 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.92%.
Which hedge fund is a major shareholder of Kindstar Globalgene Technology, Inc.?
Currently, no hedge funds are holding shares in HK:9960
Kindstar Globalgene Technology, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.14%
12-Months-Change
Fundamentals
Return on Equity
-1.93%
Trailing 12-Months
Asset Growth
-0.56%
Trailing 12-Months
Company Description
Kindstar Globalgene Technology, Inc.
Kindstar Global (Beijing) Technology, Inc. provides medical esoteric testing services to hospitals in China. Its services include medical research, drug trial, and translational medicine research services for physicians, medical science and technology institutions, specialty and general hospitals, and pharmaceutical companies. The company's lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research laboratories. It provides tests in blood, tumor, and genetics; and cardiovascular, cerebrovascular, infectious, and autoimmune diseases, as well as in internal medicine, surgery, gynecology, pediatrics, and other specialties. The company was founded in 2003 and is headquartered in in Wuhan, China.
Technical Analysis
New Century Healthcare Holding Co. Ltd.
―
Rici Healthcare Holdings Ltd.
―
Guangdong Kanghua Healthcare Co., Ltd. Class H
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―